Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The starting dose is 0.25 milligrams
Type 2 diabetes mellitus (T2D) Type 2 diabetes mellitus (T2D) is an acquired condition, characterized by systemic inflammation and increasement of cardiovascular risk and death
A Phase 2 trial (NCT01311518) was designed to test RGN-352 in ~75 heart attack patients, but was placed on FDA clinical hold in 2011 due to manufacturing (GMP) compliance issues at the contract site not safety concerns with the drug itself
Nature Medicine (2025)
"One kilogram is 4 million doses," she says
Zinc deficiency, DNA damage and cancer risk
US$ 24.08
US$ 25.82
US$ 20.17
US$ 20.02
US$ 28.09
US$ 27.47
